美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

阿庫拉製藥

0.0005

0.0000

成交量：- -

成交額：- -

市值：3.32萬

市盈率：-0.02

高：0.0005

開：0.0005

低：0.0005

收：0.0005

52周最高：0.1755

52周最低：0.0001

股本：6,649.93萬

流通股本：999.03萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.0200

每股收益(LYR):-0.0200

淨資產收益率：15.24%

總資產收益率：-58.46%

市淨率：0.19

市盈率(LYR):-0.02

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

阿庫拉製藥

交易所：

EXPERT

成立時間：

1935

員工人數：

- -

公司地址：

616 N. North Court,Suite 120,Palatine,Illinois,United States

官網：

http://www.acurapharm.com

郵編：

60067

電話：

傳真：

847 705 5399

簡介：

Acura Pharmaceuticals, Inc.是一家紐約公司，其子公司是一家專業製藥公司，從事產品和技術的研究、開發和商業化，旨在解決藥物濫用和誤用。該公司已經研發了兩項專利技術。公司的反感技術（Aversion Technology）是將惰性成分的混合物用於藥片和膠囊，旨在解決一些常見的類鴉片藥物的濫用。 Pfizer控股公司的鹽酸羥考酮片是首個被批准銷售的利用反感技術製成的藥品，是公司與 Pfizer的子公司簽訂協議后合作開發的。該公司還開發了結合非活性成分的阻礙技術,防止從藥片中提取偽麻黃鹼，防止偽麻黃鹼直接轉換成冰毒。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ACUR/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUR\",,,,,undefined,":{"symbol":"ACUR","market":"US","secType":"STK","nameCN":"阿庫拉製藥","latestPrice":0.0005,"timestamp":1773244800000,"preClose":0.0005,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":9990324,"shares":66499283,"eps":-0.02,"marketStatus":"交易中","change":0,"latestTime":"03-11 12:00:00 EDT 延時","open":0.0005,"high":0.0005,"low":0.0005,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.02,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773259200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0005,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUR\",,,,,undefined,":{"symbol":"ACUR","floatShares":9990324,"roa":"-58.46%","roe":"15.24%","lyrEps":-0.02,"shares":66499283,"dividePrice":0,"high":0.0005,"amplitude":0,"preClose":0.0005,"low":0.0005,"week52Low":0.0001,"pbRate":"0.19","psRate":"0.02","week52High":0.1755,"institutionHeld":0,"latestPrice":0.0005,"eps":-0.02,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.02,"open":0.0005,"prevYearClose":0.0005,"prevWeekClose":0.0005,"prevMonthClose":0.0005,"prevQuarterClose":0.0005,"fiveDayClose":0.0005,"twentyDayClose":0.0005,"sixtyDayClose":0.0002},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-05-17","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1621224000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-03-31","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1617163200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-11-16","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1605502800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-06-29","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1593403200000,"reportTimeType":"post","actualEps":null},{"date":"2020-06-15","symbol":"ACUR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1592251200000,"name":null,"time":"盤後","dateTimestamp":1592193600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":29262,"yearFounded":1935,"address":"616 N. North Court,Suite 120,Palatine,Illinois,United States","zipCode":"60067","officePhone":"847 705 7709","officeFax":"847 705 5399"},"stockCompanyDetail":{"websiteUrl":"http://www.acurapharm.com","stockEarnings":[{"period":"1week","weight":-0.1892},{"period":"1month","weight":0},{"period":"3month","weight":0.4925},{"period":"6month","weight":0.6575},{"period":"1year","weight":0.0345},{"period":"ytd","weight":1.611}],"description":"Acura Pharmaceuticals, Inc.是一家紐約公司，其子公司是一家專業製藥公司，從事產品和技術的研究、開發和商業化，旨在解決藥物濫用和誤用。該公司已經研發了兩項專利技術。公司的反感技術 （Aversion Technology） 是將惰性成分的混合物用於藥片和膠囊，旨在解決一些常見的類鴉片藥物的濫用。 Pfizer控股公司的鹽酸羥考酮片是首個被批准銷售的利用反感技術製成的藥品，是公司與 Pfizer的子公司簽訂協議后合作開發的。該公司還開發了結合非活性成分的阻礙技術,防止從藥片中提取偽麻黃鹼，防止偽麻黃鹼直接轉換成冰毒。","exchange":"EXPERT","name":"阿庫拉製藥","nameEN":"Acura Pharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACUR\",market:\"US\",,,undefined,":null}}